Coastline Trust CO Novartis Ag Transaction History

Coastline Trust CO

$847 Million
Q3 2024

A detailed history of Coastline Trust CO transactions in Novartis Ag stock. As of the latest transaction made, Coastline Trust CO holds 20,621 shares of NVS stock, worth $2.14 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

20,621

Previous 14,561 41.62%

Holding current value

$2.14 Million

Previous $1.55 Million 52.97%

% of portfolio

0.28%

Previous 0.19%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$106.13 - $120.89 $643,147 - $732,593	6,060 Added 41.62%	20,621 $2.37 Million
Q2 2024 Jul 15, 2024	SELL	$92.57 - $107.37 $9,257 - $10,737	-100 Reduced 0.68%	14,561 $1.55 Million
Q1 2024 Apr 26, 2024	SELL	$95.27 - $108.47 $78,121 - $88,945	-820 Reduced 5.3%	14,661 $1.42 Million
Q2 2023 Aug 07, 2023	SELL	$92.52 - $104.91 $64,486 - $73,122	-697 Reduced 4.31%	15,481 $1.56 Million
Q1 2023 May 31, 2023	SELL	$80.03 - $92.81 $8,003 - $9,281	-100 Reduced 0.61%	16,178 $1.49 Million
Q4 2022 Feb 09, 2023	SELL	$75.55 - $92.52 $72,074 - $88,264	-954 Reduced 5.54%	16,278 $1.48 Million
Q2 2022 Jul 22, 2022	SELL	$80.52 - $93.75 $43,883 - $51,093	-545 Reduced 3.07%	17,232 $1.46 Million
Q1 2022 May 04, 2022	BUY	$80.11 - $90.62 $7,370 - $8,337	92 Added 0.52%	17,777 $1.56 Million
Q4 2021 Feb 10, 2022	BUY	$79.7 - $88.13 $14,346 - $15,863	180 Added 1.03%	17,685 $1.55 Million
Q3 2021 Nov 09, 2021	BUY	$81.78 - $95.14 $16,764 - $19,503	205 Added 1.18%	17,505 $1.43 Million
Q2 2021 Aug 10, 2021	SELL	$85.24 - $94.15 $90,354 - $99,799	-1,060 Reduced 5.77%	17,300 $1.58 Million
Q1 2021 May 10, 2021	SELL	$83.5 - $98.47 $14,195 - $16,739	-170 Reduced 0.92%	18,360 $1.57 Million
Q4 2020 Feb 12, 2021	BUY	$78.07 - $94.43 $25,763 - $31,161	330 Added 1.81%	18,530 $1.75 Million
Q3 2020 Oct 15, 2020	SELL	$82.14 - $91.0 $40,248 - $44,590	-490 Reduced 2.62%	18,200 $1.58 Million
Q2 2020 Aug 07, 2020	SELL	$80.93 - $91.1 $33,585 - $37,806	-415 Reduced 2.17%	18,690 $1.63 Million
Q1 2020 Jun 10, 2020	SELL	$70.67 - $99.01 $6,713 - $9,405	-95 Reduced 0.49%	19,105 $1.58 Million
Q4 2019 Jan 15, 2020	SELL	$84.35 - $95.37 $58,623 - $66,282	-695 Reduced 3.49%	19,200 $1.82 Million
Q3 2019 Oct 18, 2019	SELL	$85.54 - $94.26 $1,283 - $1,413	-15 Reduced 0.08%	19,895 $1.73 Million
Q2 2019 Jul 18, 2019	BUY	$75.4 - $92.8 $4,524 - $5,568	60 Added 0.3%	19,910 $1.82 Million
Q1 2019 Apr 25, 2019	BUY	$75.32 - $86.15 $3,012 - $3,446	40 Added 0.2%	19,850 $1.91 Million
Q4 2018 Jan 15, 2019	BUY	$73.66 - $82.02 $41,249 - $45,931	560 Added 2.91%	19,810 $1.7 Million
Q3 2018 Oct 17, 2018	BUY	$66.94 - $77.43 $22,424 - $25,939	335 Added 1.77%	19,250 $1.66 Million
Q2 2018 Jul 27, 2018	BUY	$64.91 - $73.36 $6,815 - $7,702	105 Added 0.56%	18,915 $1.43 Million
Q1 2018 Apr 16, 2018	BUY	$70.39 - $84.15 $15,837 - $18,933	225 Added 1.21%	18,810 $1.52 Million
Q4 2017 Jan 17, 2018	SELL	$72.33 - $77.64 $172,507 - $185,171	-2,385 Reduced 11.37%	18,585 $1.56 Million
Q3 2017 Nov 17, 2017	BUY	$74.14 - $77.27 $115,658 - $120,541	1,560 Added 8.04%	20,970 $1.8 Million
Q2 2017 Aug 10, 2017	BUY	N/A	19,410	19,410 $1.62 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Coastline Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Coastline Trust CO with notifications on news.

Account

Coastline Trust CO Novartis Ag Transaction History